Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 42(2): 573-7, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304195

RESUMO

Cell phenotype evaluation enables better understanding of the rejection process in experimental transplantation. We studied allograft survival and the mechanisms associated with rejection in a murine model of skin transplantation in the absence of immunosuppression or after FTY720 or sirolimus (SRL) administration for 21 days. Leukocyte phenotype was evaluated in the peripheral blood, spleen, axillary lymph nodes, thymus gland, and skin graft using flow cytometry at 5 days posttransplantation. Treatment with FTY720 plus SRL increased skin allograft survival in association with lymphopenia, reduced CD11b+ and CD3+CD4+ cell percentages in the graft, decreased CD3+CD4+, CD3+CD8+, and CD11b+ cell counts in lymphoid organs, and decreased CD4+CD8+ cell count in the thymus. These results suggest that increased allograft survival in animals treated with FTY720 plus SRL is due to possible impairment of antigen presentation or recognition in the graft and secondary lymphoid organs, and decreased emigration of mature thymocytes to the periphery.


Assuntos
Imunossupressores/uso terapêutico , Propilenoglicóis/uso terapêutico , Sirolimo/uso terapêutico , Transplante de Pele/imunologia , Esfingosina/análogos & derivados , Animais , Contagem de Células , Cloridrato de Fingolimode , Citometria de Fluxo , Sobrevivência de Enxerto/imunologia , Contagem de Leucócitos , Leucócitos/citologia , Leucócitos/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Modelos Animais , Fenótipo , Pele/citologia , Esfingosina/uso terapêutico , Transplante Homólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...